News Release

HHMI bets big on 19 new investigators

Grant and Award Announcement

Howard Hughes Medical Institute

2018 HHMI Investigators

image: The Howard Hughes Medical Institute will invest $200 million in 19 new HHMI Investigators. view more 

Credit: HHMI

Beth Shapiro has dug for prehistoric bones in Siberia. Ralph DeBerardinis has improved the lives of kids with metabolic diseases. Jesse Bloom has uncovered genetic secrets that could help fight the flu.

Shapiro, DeBerardinis, and Bloom are among 19 scientists whose work is dramatically advancing our understanding of cells, the brain, metabolism, and more. Today, these scientists all share a new title: Howard Hughes Medical Institute (HHMI) Investigator.

On May 23, 2018, HHMI announced that it will invest $200 million in this new cadre of investigators, a group of individuals known for pushing the boundaries of biomedical research. "We selected these scientists because they know how to ask hard and interesting questions with skill and intellectual courage," says David Clapham, HHMI's vice president and chief scientific officer. "We believe they have the potential to make breakthroughs over time."

Each of the 19 new investigators will receive roughly $8 million over a seven-year term, which is renewable pending a scientific review. In addition, investigator support includes a guaranteed two-year transition period. This new group of investigators is the first to be appointed to a seven-year term (previous terms lasted five years). HHMI selected the new investigators from a pool of 675 eligible applicants. The scientists represent 15 U.S. institutions and will join an investigator community that now numbers over 300.

"Every scientist is unique, but they all need one thing: time," says HHMI President Erin O'Shea. "HHMI is dedicated to providing outstanding biomedical scientists with the time and resources to do their best work. We think of this as investing in people, not just projects."

To date, 28 current or former HHMI scientists have won the Nobel Prize. Investigators have made big leaps forward in HIV vaccine development, microbiome and circadian rhythm research, immunotherapy, and the genome editing tool known as CRISPR/Cas9, among other fields.

2018 HHMI Investigators

Thomas Bernhardt, PhD
Harvard Medical School

Jesse Bloom, PhD
Fred Hutchinson Cancer Research Center

Edward Boyden, PhD
Massachusetts Institute of Technology

Clifford Brangwynne, PhD
Princeton University

Howard Chang, MD, PhD
Stanford University

Ralph DeBerardinis, MD, PhD
University of Texas Southwestern Medical Center

Benjamin Ebert, MD, PhD
Dana-Farber Cancer Institute

Zachary Knight, PhD
University of California, San Francisco

Stephen Liberles, PhD
Harvard Medical School

Zachary Lippman, PhD
Cold Spring Harbor Laboratory

Gaby Maimon, PhD
The Rockefeller University

Luciano Marraffini, PhD
The Rockefeller University

Samara Reck-Peterson, PhD
University of California, San Diego

Elizabeth Sattely, PhD
Stanford University

Beth Shapiro, DPhil
University of California, Santa Cruz

Beth Stevens, PhD
Boston Children's Hospital

Gia Voeltz, PhD
University of Colorado Boulder

Meng Wang, PhD
Baylor College of Medicine

Feng Zhang, PhD
Massachusetts Institute of Technology


The Howard Hughes Medical Institute plays an important role in advancing scientific research and education in the United States. Its scientists, located across the country and around the world, have made important discoveries that advance both human health and our fundamental understanding of biology. The Institute also aims to transform science education into a creative, interdisciplinary endeavor that reflects the excitement of real research. HHMI's headquarters are located in Chevy Chase, Maryland, just outside Washington, D.C.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.